Clinical Trial Update: ARISE-A Chinese Real-world Study of Rimegepant for the Acute Treatment of Migraine

View source ↗

Summary

Chinese ARISE-A real-world study evaluating rimegepant for acute treatment of migraine is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Rimegepant (rimegepant)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Migraine | Status: ACTIVE_NOT_RECRUITING